Bioxytran, Inc.

Bioxytran, Inc.verified

BIXT

Price:

$0.14275

Market Cap:

$12.69M

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated ...[Read more]

Industry

Biotechnology

IPO Date

2010-01-05

Stock Exchange

PNK

Ticker

BIXT

The PE Ratio as of May 2025 (TTM) for Bioxytran, Inc. (BIXT) is -7.14

According to Bioxytran, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.14. This represents a change of 15.32% compared to the average of -6.19 of the last 4 quarters.

Bioxytran, Inc. (BIXT) Historical PE Ratio (quarterly & annually)

How has BIXT PE Ratio performed in the past?

The mean historical PE Ratio of Bioxytran, Inc. over the last ten years is -20.75. The current -7.14 PE Ratio has changed 3.34% with respect to the historical average. Over the past ten years (40 quarters), BIXT's PE Ratio was at its highest in in the September 2017 quarter at 1.39. The PE Ratio was at its lowest in in the September 2022 quarter at -163.09.

Quarterly (TTM)
Annual

Average

-20.75

Median

-5.64

Minimum

-146.43

Maximum

-0.00

Bioxytran, Inc. (BIXT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bioxytran, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.88%

Maximum Annual PE Ratio = -0.00

Minimum Annual Increase = -92.04%

Minimum Annual PE Ratio = -146.43

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.2611.92%
2023-4.70-79.03%
2022-22.43129.33%
2021-9.7862.83%
2020-6.01-48.47%
2019-11.66-92.04%
2018-146.4320.72%
2017-0.7045.75%
2016-0.485.88%
2015-0.00451.38%

Bioxytran, Inc. (BIXT) Average PE Ratio

How has BIXT PE Ratio performed in the past?

The current PE Ratio of Bioxytran, Inc. (BIXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-10.80

5-year avg

-9.64

10-year avg

-20.75

Bioxytran, Inc. (BIXT) PE Ratio vs. Peers

How is BIXT’s PE Ratio compared to its peers?

Bioxytran, Inc.’s PE Ratio is less than Biotron Limited (-2.11), less than Bioasis Technologies Inc. (0), less than Covalon Technologies Ltd. (15.01), less than Mosaic ImmunoEngineering Inc. (-1.56), less than Ceapro Inc. (-2.83), less than Cellectis S.A. (-3.65), less than Oxford Cannabinoid Technologies Holdings Plc (0), less than Neurobiological Technologies, Inc. (-0.19), less than Pharming Group N.V. (0), greater than Health Sciences Group, Inc. (-60.63), less than MedMira Inc. (0), greater than null (-13.39),

Build a custom stock screener for Bioxytran, Inc. (BIXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioxytran, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bioxytran, Inc. (BIXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bioxytran, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bioxytran, Inc.'s PE Ratio?

How is the PE Ratio calculated for Bioxytran, Inc. (BIXT)?

What is the highest PE Ratio for Bioxytran, Inc. (BIXT)?

What is the 3-year average PE Ratio for Bioxytran, Inc. (BIXT)?

What is the 5-year average PE Ratio for Bioxytran, Inc. (BIXT)?

How does the current PE Ratio for Bioxytran, Inc. (BIXT) compare to its historical average?